These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 29268054)

  • 1. Pharmacological management of cystic fibrosis related diabetes.
    Moheet A; Moran A
    Expert Rev Clin Pharmacol; 2018 Feb; 11(2):185-191. PubMed ID: 29268054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.
    Piechowiak K; Trippenbach-Dulska H; Walicka-Serzysko K
    Dev Period Med; 2015; 19(1):80-91. PubMed ID: 26003073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystic Fibrosis-Related Diabetes in Children: An Update.
    Kim RJ
    Pediatr Ann; 2016 Sep; 45(9):e321-6. PubMed ID: 27622916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis].
    Khammar A; Stremler N; Dubus JC; Gross G; Sarles J; Reynaud R
    Arch Pediatr; 2009 Dec; 16(12):1540-6. PubMed ID: 19854630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in response to insulin and the effects of varying glucose tolerance on whole-body protein metabolism in patients with cystic fibrosis.
    Rafii M; Chapman K; Stewart C; Kelly E; Hanna A; Wilson DC; Tullis E; Pencharz PB
    Am J Clin Nutr; 2005 Feb; 81(2):421-6. PubMed ID: 15699230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes in cystic fibrosis.
    Bridges N
    Paediatr Respir Rev; 2013 May; 14 Suppl 1():16-8. PubMed ID: 23522600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy of diabetes in cystic fibrosis patients.
    Hardin DS
    Expert Opin Pharmacother; 2010 Apr; 11(5):771-8. PubMed ID: 20166842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose intolerance in cystic fibrosis patients.
    Lanng S
    Paediatr Respir Rev; 2001 Sep; 2(3):253-9. PubMed ID: 12052327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained Glycemic Control With Ivacaftor in Cystic Fibrosis-Related Diabetes.
    Christian F; Thierman A; Shirley E; Allen K; Cross C; Jones K
    J Investig Med High Impact Case Rep; 2019; 7():2324709619842898. PubMed ID: 31010313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open randomised prospective comparative multi-centre intervention study of patients with cystic fibrosis and early diagnosed diabetes mellitus.
    Ballmann M; Hubert D; Assael BM; Kronfeld K; Honer M; Holl RW;
    BMC Pediatr; 2014 Mar; 14():70. PubMed ID: 24620855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CF-related diabetes: Containing the metabolic miscreant of cystic fibrosis.
    Moheet A; Moran A
    Pediatr Pulmonol; 2017 Nov; 52(S48):S37-S43. PubMed ID: 28714601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosing cystic fibrosis-related diabetes: current methods and challenges.
    Prentice B; Hameed S; Verge CF; Ooi CY; Jaffe A; Widger J
    Expert Rev Respir Med; 2016 Jul; 10(7):799-811. PubMed ID: 27268400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of glucose intolerance in cystic fibrosis.
    Mohan K; Miller H; Dyce P; Grainger R; Hughes R; Vora J; Ledson M; Walshaw M
    Diabet Med; 2009 Jun; 26(6):582-8. PubMed ID: 19538232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes and Prediabetes in Children With Cystic Fibrosis: A Systematic Review of the Literature and Recommendations of the Italian Society for Pediatric Endocrinology and Diabetes (ISPED).
    Mozzillo E; Franceschi R; Piona C; Passanisi S; Casertano A; Pjetraj D; Maltoni G; Calcaterra V; Cauvin V; Cherubini V; D'Annunzio G; Franzese A; Frongia AP; Lombardo F; Lo Presti D; Matteoli MC; Piccinno E; Predieri B; Rabbone I; Scaramuzza AE; Toni S; Zucchini S; Maffeis C; Schiaffini R
    Front Endocrinol (Lausanne); 2021; 12():673539. PubMed ID: 34017312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical importance of cystic fibrosis-related diabetes.
    Brennan AL; Geddes DM; Gyi KM; Baker EH
    J Cyst Fibros; 2004 Dec; 3(4):209-22. PubMed ID: 15698938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for cystic fibrosis-related diabetes: a systematic review.
    Waugh N; Royle P; Craigie I; Ho V; Pandit L; Ewings P; Adler A; Helms P; Sheldon C
    Health Technol Assess; 2012; 16(24):iii-iv, 1-179. PubMed ID: 22572153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the detection and management of cystic fibrosis related diabetes.
    Hameed S; Jaffé A; Verge CF
    Curr Opin Pediatr; 2015 Aug; 27(4):525-33. PubMed ID: 26087430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic fibrosis related diabetes (CFRD)--the end stage of progressive insulin deficiency.
    Hameed S; Jaffé A; Verge CF
    Pediatr Pulmonol; 2011 Aug; 46(8):747-60. PubMed ID: 21626717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial.
    Moran A; Pekow P; Grover P; Zorn M; Slovis B; Pilewski J; Tullis E; Liou TG; Allen H;
    Diabetes Care; 2009 Oct; 32(10):1783-8. PubMed ID: 19592632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of cystic fibrosis-related diabetes on health-related quality of life.
    Kwong E; Desai S; Chong L; Lee K; Zheng J; Wilcox PG; Quon BS
    J Cyst Fibros; 2019 Sep; 18(5):734-736. PubMed ID: 30935840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.